Annual Current Liabilities
$361.11 M
-$24.44 M-6.34%
31 March 2024
Summary:
Taro Pharmaceutical Industries annual total current liabilities is currently $361.11 million, with the most recent change of -$24.44 million (-6.34%) on 31 March 2024. During the last 3 years, it has fallen by -$315.19 million (-46.61%).TARO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$361.11 M
-$12.95 M-3.46%
31 March 2024
Summary:
Taro Pharmaceutical Industries quarterly total current liabilities is currently $361.11 million, with the most recent change of -$12.95 million (-3.46%) on 31 March 2024. Over the past year, it has dropped by -$381.00 thousand (-0.11%).TARO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.3% | -0.1% |
| 3 y3 years | -46.6% | -41.2% |
| 5 y5 years | +66.5% | +72.4% |
TARO Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -46.6% | -50.5% |
Taro Pharmaceutical Industries Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $361.11 M(-6.3%) | $361.11 M(-3.5%) |
| Dec 2023 | - | $374.06 M(+3.5%) |
| Sept 2023 | - | $361.49 M(-6.1%) |
| June 2023 | - | $385.01 M(-0.1%) |
| Mar 2023 | $385.55 M(-10.8%) | $385.55 M(+2.9%) |
| Sept 2022 | - | $374.85 M(+0.1%) |
| June 2022 | - | $374.45 M(-13.3%) |
| Mar 2022 | $432.12 M(-36.1%) | $432.12 M(+9.5%) |
| Dec 2021 | - | $394.79 M(-35.7%) |
| Sept 2021 | - | $613.96 M(-15.8%) |
| June 2021 | - | $729.15 M(+7.8%) |
| Mar 2021 | $676.30 M(+203.6%) | $676.30 M(+15.8%) |
| Dec 2020 | - | $584.08 M(-0.6%) |
| Sept 2020 | - | $587.32 M(-1.5%) |
| June 2020 | - | $596.49 M(+167.8%) |
| Mar 2020 | $222.73 M(+2.7%) | $222.73 M(+4.0%) |
| Dec 2019 | - | $214.18 M(+2.2%) |
| Sept 2019 | - | $209.50 M(+10.7%) |
| June 2019 | - | $189.23 M(-12.7%) |
| Mar 2019 | $216.82 M(+0.5%) | $216.82 M(-0.8%) |
| Dec 2018 | - | $218.64 M(+7.7%) |
| Sept 2018 | - | $203.06 M(+5.4%) |
| June 2018 | - | $192.63 M(-10.7%) |
| Mar 2018 | $215.76 M(+2.8%) | $215.76 M(+1.0%) |
| Dec 2017 | - | $213.57 M(+6.0%) |
| Sept 2017 | - | $201.55 M(-2.1%) |
| June 2017 | - | $205.77 M(-1.9%) |
| Mar 2017 | $209.84 M(-14.5%) | $209.84 M(-12.4%) |
| Dec 2016 | - | $239.46 M(+6.0%) |
| Sept 2016 | - | $225.97 M(-7.2%) |
| June 2016 | - | $243.38 M(-0.8%) |
| Mar 2016 | $245.46 M(-20.8%) | $245.46 M(-15.5%) |
| Dec 2015 | - | $290.42 M(+5.2%) |
| Sept 2015 | - | $275.97 M(+10.8%) |
| June 2015 | - | $249.00 M(-19.7%) |
| Mar 2015 | $310.00 M(+22.4%) | $310.00 M(+16.3%) |
| Dec 2014 | - | $266.52 M(+13.6%) |
| Sept 2014 | - | $234.68 M(-6.3%) |
| June 2014 | - | $250.50 M(-1.1%) |
| Mar 2014 | $253.30 M(+31.6%) | $253.30 M(+3.8%) |
| Dec 2013 | - | $243.93 M(+7.3%) |
| Sept 2013 | - | $227.39 M(+7.5%) |
| June 2013 | - | $211.46 M(+9.8%) |
| Mar 2013 | $192.53 M(-3.2%) | $192.53 M(+10.8%) |
| Dec 2012 | - | $173.84 M(+1.0%) |
| Sept 2012 | - | $172.19 M(+8.9%) |
| June 2012 | - | $158.11 M(-20.5%) |
| Mar 2012 | $198.90 M(+4.5%) | $198.90 M(+4.5%) |
| Dec 2011 | $190.38 M(+46.7%) | $190.38 M(+10.0%) |
| Sept 2011 | - | $173.01 M(+30.7%) |
| June 2011 | - | $132.36 M(-1.5%) |
| Mar 2011 | - | $134.44 M(+3.6%) |
| Dec 2010 | $129.79 M(-43.7%) | $129.79 M(-33.5%) |
| Sept 2010 | - | $195.11 M(-9.2%) |
| June 2010 | - | $214.97 M(-6.7%) |
| Dec 2009 | $230.41 M | $230.41 M(+2.2%) |
| Sept 2009 | - | $225.50 M(+16.8%) |
| June 2009 | - | $193.06 M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $185.18 M(-22.7%) |
| Dec 2008 | $239.40 M(+2.8%) | $239.40 M(+16.0%) |
| Sept 2008 | - | $206.31 M(-17.6%) |
| Dec 2007 | $232.87 M(-11.7%) | - |
| Dec 2006 | $263.58 M(+5.3%) | - |
| Dec 2005 | $250.40 M(+90.4%) | $250.40 M(+96.7%) |
| Sept 2005 | - | $127.29 M(-6.8%) |
| June 2005 | - | $136.64 M(+8.4%) |
| Mar 2005 | - | $126.08 M(-4.1%) |
| Dec 2004 | $131.53 M(+26.8%) | $131.53 M(+23.3%) |
| Sept 2004 | - | $106.65 M(+11.5%) |
| June 2004 | - | $95.64 M(-5.3%) |
| Mar 2004 | - | $100.99 M(-2.7%) |
| Dec 2003 | $103.74 M(+78.1%) | $103.74 M(+10.4%) |
| Sept 2003 | - | $94.00 M(+23.7%) |
| June 2003 | - | $75.98 M(-5.4%) |
| Mar 2003 | - | $80.28 M(+37.8%) |
| Dec 2002 | $58.24 M(+67.4%) | $58.24 M(+39.3%) |
| Sept 2002 | - | $41.80 M(-5.6%) |
| June 2002 | - | $44.28 M(+36.8%) |
| Mar 2002 | - | $32.38 M(-6.9%) |
| Dec 2001 | $34.78 M(+23.6%) | $34.78 M(+13.7%) |
| Sept 2001 | - | $30.60 M(+0.7%) |
| June 2001 | - | $30.39 M(+9.9%) |
| Mar 2001 | - | $27.65 M(-1.8%) |
| Dec 2000 | $28.15 M(+13.7%) | $28.15 M(-18.0%) |
| Sept 2000 | - | $34.33 M(+21.8%) |
| June 2000 | - | $28.18 M(-2.8%) |
| Mar 2000 | - | $28.99 M(+17.1%) |
| Dec 1999 | $24.76 M(-10.9%) | $24.76 M(-9.6%) |
| Sept 1999 | - | $27.40 M(-17.5%) |
| June 1999 | - | $33.20 M(+19.9%) |
| Mar 1999 | - | $27.70 M(-0.4%) |
| Dec 1998 | $27.80 M(+2.2%) | $27.80 M(-14.7%) |
| Mar 1998 | - | $32.60 M(+19.9%) |
| Dec 1997 | $27.20 M(+34.7%) | $27.20 M(+1.1%) |
| Sept 1997 | - | $26.90 M(+15.9%) |
| June 1997 | - | $23.20 M(+7.4%) |
| Mar 1997 | - | $21.60 M(+6.9%) |
| Dec 1996 | $20.20 M(+49.6%) | $20.20 M(+13.5%) |
| Sept 1996 | - | $17.80 M(+2.3%) |
| June 1996 | - | $17.40 M(+16.0%) |
| Mar 1996 | - | $15.00 M(+11.1%) |
| Dec 1995 | $13.50 M(-28.6%) | $13.50 M(-28.6%) |
| Dec 1994 | $18.90 M(+40.0%) | $18.90 M(+40.0%) |
| Dec 1993 | $13.50 M(+21.6%) | $13.50 M(+21.6%) |
| Dec 1992 | $11.10 M(+63.2%) | $11.10 M(+19.4%) |
| Sept 1992 | - | $9.30 M(+32.9%) |
| June 1992 | - | $7.00 M(+9.4%) |
| Mar 1992 | - | $6.40 M(-5.9%) |
| Dec 1991 | $6.80 M(+19.3%) | $6.80 M(-5.6%) |
| Sept 1991 | - | $7.20 M(+7.5%) |
| June 1991 | - | $6.70 M(+15.5%) |
| Mar 1991 | - | $5.80 M(+1.8%) |
| Dec 1990 | $5.70 M(+39.0%) | $5.70 M(+42.5%) |
| Mar 1990 | - | $4.00 M(-2.4%) |
| Dec 1989 | $4.10 M(+41.4%) | $4.10 M(+41.4%) |
| Dec 1988 | $2.90 M(+7.4%) | $2.90 M(+7.4%) |
| Dec 1987 | $2.70 M | $2.70 M |
FAQ
- What is Taro Pharmaceutical Industries annual total current liabilities?
- What is the all time high annual current liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual current liabilities year-on-year change?
- What is Taro Pharmaceutical Industries quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly current liabilities year-on-year change?
What is Taro Pharmaceutical Industries annual total current liabilities?
The current annual current liabilities of TARO is $361.11 M
What is the all time high annual current liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual total current liabilities is $676.30 M
What is Taro Pharmaceutical Industries annual current liabilities year-on-year change?
Over the past year, TARO annual total current liabilities has changed by -$24.44 M (-6.34%)
What is Taro Pharmaceutical Industries quarterly total current liabilities?
The current quarterly current liabilities of TARO is $361.11 M
What is the all time high quarterly current liabilities for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly total current liabilities is $729.15 M
What is Taro Pharmaceutical Industries quarterly current liabilities year-on-year change?
Over the past year, TARO quarterly total current liabilities has changed by -$381.00 K (-0.11%)